Sustained Virologic Response at 24 Weeks after the End of Treatment Is a Better Predictor for Treatment Outcome in Real-World HCV-Infected Patients Treated by HCV NS3/4A Protease Inhibitors with Peginterferon plus Ribavirin

Background. Direct-acting antiviral agents against HCV with or without peginterferon plus ribavirin result in higher eradication rates of HCV and shorter treatment duration. We examined which is better for predicting persistent virologic response, the assessment of serum HCV RNA at 12 or 24 weeks af...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
הוצא לאור ב:Int J Med Sci
Main Authors: Kanda, Tatsuo, Nakamoto, Shingo, Sasaki, Reina, Nakamura, Masato, Yasui, Shin, Haga, Yuki, Ogasawara, Sadahisa, Tawada, Akinobu, Arai, Makoto, Mikami, Shigeru, Imazeki, Fumio, Yokosuka, Osamu
פורמט: Artigo
שפה:Inglês
יצא לאור: Ivyspring International Publisher 2016
נושאים:
Research Paper
גישה מקוונת:https://ncbi.nlm.nih.gov/pmc/articles/PMC4829545/
https://ncbi.nlm.nih.gov/pubmed/27076789
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/ijms.14953
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!

פריטים דומים